
本书作者原创一种新型纳米金微芯片,并整合细胞核和细胞质蛋白的纯化结果和生物计算技术(如DB索引算法,由距离矩阵、色彩相似性等决定聚类边界),通过分子标注和击打次数,建立细胞信号转导模型。该系统具有高特异性、高敏感性、高重复性、高稳定性、高信号性、样本检测量大、简便性、安全性、多参数实时定量的特点,通过计算后可建立分子机制网络。
"Genome-scale analyses have allowed us to progress beyond the studies of gene expression, to the level of individual components of a given process by providing global information about functional connections between genes, mRNAs and their regulatory proteins. Such analyses have greatly increased our understanding of the interplay between different events in gene regulation that have previously highlighted unappreciated functional connections, including coupling between nuclear and cytoplasmic processes. Overall, these studies enhance our understanding of how the various components of the eukaryotic cell function as a system, to allow both coordination and versatility in gene expression" (Komili et al. 2008).
With the post-genome era, the proteomics study of direct analysis of proteins has become more and more important (James et al. 1997). Identification of the type of modification and its location in a protein structure often provides crucial information for understanding the function or regulation of a given protein in the biological pathways (Zhu et al. 2003).
Phosphorylation is one of the most important protein modifications, by which many different cellular responses and biological processes are regulated.
Protein-localization data provide valuable information in elucidating eukaryotic protein function (Zhu et al. 2003). Protein trafficking between nucleus and cytoplasm is fundamentally important in cell regulation. As such, the nuclear import and export are pivotal in orchestrating the activities of the key regulators of the cell cycle (Zhou et al. 2003).
"The discovery of regulatory networks is an important aspect in the post-genomic research. The process requires integrated efforts of experimental and computational strategies by employing the system's biology approach" (Li et al. 2008).
This book describes the new biochip nano-gold antibody-microarray tube, which was developed with the incorporation of protein localization and computation technologies for setting-up signaling pathways, where the information of discovery is also conveyed through various illustrations and tables, from which the reader can not only learn new technologies, but also gain knowledge about the protein localization, signaling pathways and protein relationships.
Chapter 1 Introduction 1
1.1 Antibody Array Technologies and Applications 1
1.2 Protein Phosphorylation, Localization and Function 3
1.3 Interaction Proteomics and Pathway Building 4
1.3.1 BMP2 Signaling 5
1.3.2 The Effect of STI571 on Cell Signaling 11
Chapter 2 Technologies 12
2.1 Materials 12
2.1.1 Cell Lines 12
2.1.2 Chemicals 12
2.1.3 Antibodies 12
2.1.4 Protein-Molecular Weight Marker 13
2.1.5 Apparatus 13
2.2 Methods 14
2.2.1 Cell Culture 14
2.2.2 Cell Numbers and Experimental Format 14
2.2.3 Cytoplasmic and Nuclear Protein Extracts 14
2.2.4 Determination of Protein Concentration 15
2.2.5 Ponceau S Staining 15
2.2.6 Western Analysis 16
2.2.7 Immunoprecipitation 16
2.2.8 Cell Cycle Analysis 16
2.3 Silver Staining in ArrayTube 17
2.3.1 Biotinylation of Cellular Proteins 17
2.3.2 Incubation of Protein Extracts 17
2.3.3 Silver Staining 17
2.3.4 Statistical Analysis 18
Chapter 3 New Cytoplasmic and Nuclear BMP2-Signaling Pattern in U937 Cells 23
3.1 Modulation of Phosphorylation and Localization in BMP2-Treated U937 Cells 23
3.1.1 Total p-Tyrosine and p-p38, p38 Increased: Increasing Cytoplasm and Nucleus 23
3.1.2 Total p-ERK and p-JNK Increased: Increasing Cytoplasm and Unchanged Nucleus 25
3.1.3 Total p-Akt Increased: Increasing Cytoplasm and Decreasing Nucleus 26
3.1.4 Total p-Smad1, p-Smad2/3, c-Myc and p-STAT3 Unchanged: Decreasing Cytoplasm and Increasing Nucleus 29
3.1.5 Total p-p70S6 Unchanged: Increasing Cytoplasm and Decreasing Nucleus 32
3.2 BMP2 Signaling in U937 Cells 32
3.2.1 BMP2 Activates Akt, ERK and JNK Pathway in U937 Cells 33
3.2.2 BMP2 Activates Smad1 and Smad2/3 Networks, p38 Network and c-Myc, Tyrosine Network in U937 Cells 35
3.2.3 BMP2 Inhibits p70S6 Signaling in U937 cells 36
3.3 BMP2 Signaling Model in U937 Cells 38
Chapter 4 New Cytoplasmic and Nuclear BMP2-Signaling in MCF7 Cells 40
4.1 Modulation of Phosphorylation and Localization in BMP2-Treated MCF7 Cells 40
4.1.1 Total p-JNK, p-Smad1, p-Smad2/3, p-p38 and p38 Unchanged: Increasing Cytoplasm and Decreasing Nucleus 41
4.1.2 p-Tyrosine, p-STAT3, p-ERK and p-p70S6 Increased: Increasing Cytoplasm and Unchanged Nucleus 45
4.1.3 Total c-Myc Unchanged: Slightly Increasing Nucleus and Slightly Decreasing Cytoplasm 46
4.1.4 Total p-Akt Unchanged: Unchanged Nucleus and Cytoplasm 46
4.2 BMP2 Signaling in MCF7 Cells 48
4.2.1 BMP2 Activates p70S6 and ERK Signaling, Tyrosine and STAT3 Network in MCF7 Cells 48
4.2.2 BMP2 Inhibits p38, JNK and Smad Signaling in MCF7 Cells 49
4.2.3 BMP2 Activates c-Myc Signaling in MCF7 Cells 50
4.3 BMP2 Signaling Model in MCF7 Cells 50
Chapter 5 New Cytoplasmic and Nuclear STI571 Signaling in K562 Cells 52
5.1 Modulation of Phosphorylation and Localization in STI571-Treated K562 Cells 52
5.1.1 Total p-Akt and p-p70S6 Decreased: Decreasing Cytoplasm and Nucleus 52
5.1.2 Total p-p38, p38, c-Myc, p-Tyrosine, p-Smad1 and p-Smad2/3 Increased: Increasing Cytoplasm and Nucleus 55
5.1.3 Total p-STAT3 and p-JNK Increased: Increasing Cytoplasm and Unchanged Nucleus 56
5.1.4 Total p-ERK Increased: Decreasing Cytoplasm and Increasing Nucleus 58
5.2 STI571 Signaling in K562 Cells 58
5.2.1 STI571 Inhibits Akt/p70S6 PI3K Signaling in K562 Cells 58
5.2.2 STI571 Activates p38 MAPK Pathway, c-Myc, Tyrosine and Smad1/ Smad2/ Smad3 Networks in K562 Cells 59
5.2.3 STI571 Activates ERK Pathway in K562 Cells 59
5.2.4 STI571 Activates STAT3 Network and JNK/MAPK Pathway in K562 Cells 60
5.3 STI571 Signaling Model in K562 Cells 61
Chapter 6 Positive and Negative Co-localized Relationships in Three Treated Cell Lines 63
6.1 Positive and Negative Co-localized Distributions 63
6.1.1 p-p38 and p38 63
6.1.2 Smad1 and Smad2/3 63
6.1.3 Akt, ERK and p70S6 63
6.1.4 p70S6 with p38 and Smad1, 2, 3 75
6.1.5 ERK or p38 with Smad1 80
6.1.6 ERK or p38 with c-Myc 81
6.2 Possible Relationships 83
Chapter 7 Cytoplasmic Signaling in Three Treated Cell Lines 87
7.1 Cytoplasmic Distribution 87
7.1.1 p-ERK, p-JNK and p-Akt in BMP2-Induced Apoptosis in U937 Cells 87
7.1.2 p-STAT3 and p-JNK in STI571-Treated K562 Cells 87
7.1.3 p-Tyrosine, p-STAT3, p-ERK and p-p70S6 in BMP2-Treated MCF7 Cells 91
7.2 Co-cytoplasmic Signaling 92
Chapter 8 Proteomic Silencing in Treated Human Cancer Cell Lines 95
8.1 Proteomic Silence Distributions 95
8.1.1 p-p70S6 Nuclear Decrease in BMP2-Induced Apoptosis in U937 Cells 95
8.1.2 p-ERK/p-JNK/p-p38, p-Smad1 and p-Smad2/3 Co-nuclear Decrease in BMP2-Treated MCF7 Cells 98
8.1.3 p-Akt and p-p70S6 Co-cytoplasmic and Co-nuclear Decrease in STI571-Treated K562 Cells 98
8.2 Possible Relationships 98
Chapter 9 Signaling Pathway Setting-up Based on Bioinformatics 100
9.1 Methods 100
9.1.1 Mean and Variance 100
9.1.2 Hierarchical Clustering 101
9.1.3 Competitive Learning Network 101
9.1.4 Self-Organizing Map (SOM) 104
9.2 Results 106
9.2.1 Mean and Variance Analysis of Cytoplasmic Signaling in Control and STI571-Treated K562 cells 106
9.2.2 Competitive Learning Network Analysis of Cytoplasmic Signaling in Control and STI571-Treated K562 cells 107
9.2.3 Hierarchical Clustering Analysis of Cytoplasmic Signaling in Control and STI571-Treated K562 cells 109
9.2.4 SOM Analysis of Cytoplasmic Signaling in Control and STI571-Treated K562 cells 110
9.3 Discussion 117
9.4 Conclusions 118
References 119